Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

SERNOVA CORP V.SVA

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  SEOVF

Sernova Corp is a clinical stage biotechnology company. It is engaged in the research and development of a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases.
Price: $0.265 Volume: 27,955
Change: $-0.01 % Change: -3.64%
Day High/Low: 0.28/0.265 52 Week High/Low: 0.33/0.125
Last Traded: July 31, 2015 11:57 Transaction Volume: 2000
Open: 0.265 Previous Close: 0.275
Bid: 0.265 Ask: 0.28
Bid Size: 11000 Ask Size: 41000
Market Cap: 37.4m Shares Out: 141.2m
PE Ratio: N/A Dividend Yield: N/A

Opinion

Sernova (V.SVA) puts focus on diabetes treatment device

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   May 16, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Progress update on Sernova and N.A. Nickel

Sernova’s product focus is on treating insulin-dependent diabetes. NAN is focused on greenfields nickel exploration.

Richard (Rick) Mills   July 17, 2012
0 stars

Latest Bullboard Posts